pISSN 1226-6051
eISSN 2508-786X

Table. 6.

Table. 6.

Potential adverse drug event (ADE) probability list for cost avoidance analysis

Primary domain Detail (Potential ADE probability) Sum of potential ADE probability Number of interven (%)
Order modification Dosage or frequency (0.6) 47.4 79(30.4%)
Drug-drug interaction (0.6) 9 15(5%)
Adverse drug event (0.6) 4.8 8(3.1%)
Suggestion of more appropriate medication (0.4) 3.6 9(3.5%)
Administration (rate/concentration/diluent) (0.4) 2.8 7(2.7%)
No indication (0.4) 2 5(1.9%)
Inappropriate medication combination (0.4) 1.6 4(1.5%)
Contraindication (0.6) 1.2 2(0.8%)
Duration or quantity (0.1) 0.5 5(1.9%)
Route or dosage form (0.1) 0.4 1(0.4%)
Wrong strength (0.1) 0.2 2(0.8%)
Others (0) 0 32(12.3%)
Monitoring of drug therapy Serum medication level (0.6) 4.8 8(3.1%)
Adverse drug event (0.4) 0.8 2(0.8%)
Efficacy of drug medication (0.4) 0.4 1(0.4%)
Key-in error Omission of medication (0.4) 20 50(19.2%)
Dosage/frequency/administration (0.4) 5.2 13(5.0%)
Medication item (0.4) 1.2 3(1.2%)
Duplication of medication orders (0.1) 0.1 1(0.4%)
Discontinuation of unnecessary medication (0.01) 0.09 9(3.5%)
Quantity/duration/date (0.01) 0.04 4(1.5%)
Total 105.83 260(100%)
Korean J Clin Pharm 2022;32:215-25 https://doi.org/10.24304/kjcp.2022.32.3.215
© 2022 Korean J Clin Pharm